RN7SL513P

Across TCGA pan-cancer cohorts, RN7SL513P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SL513P’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where RN7SL513P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL513P is over-expressed in tumor, although a few such as THCA and HNSC show the opposite, repressed pattern.

LIHC, LUAD, and CHOL are the cancer types where RN7SL513P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL513P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	II,III,IV	+0.120	.004	6	view →
LUAD	All	All	+0.213	.007	5	view →
CHOL	All	All	+0.180	.009	1	view →
THCA	Female	II,III,IV	−0.096	.048	1	view →
HNSC	All	II,III,IV	−0.042	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RN7SL513P–LIHC

Open the LIHC breakdown →